Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Pharmaceutics ; 13(10)2021 Oct 11.
Article in English | MEDLINE | ID: mdl-34683953

ABSTRACT

The different effects on animals of the thrombolytic protease complex of the new producer S. strictum 203 were studied. The tests of acute toxicity, immunotoxicity and allergenicity should conclude that the studied proteolytic complex is safe for medical usage. For the intravenous and the intraperitoneal routes of administration, the maximum tolerated dose and the median lethal dose were not determined.

2.
Brain Res Bull ; 173: 1-13, 2021 08.
Article in English | MEDLINE | ID: mdl-33892082

ABSTRACT

Subcutaneous administration of rotenone to rats is currently a widely used method of reproducing Parkinson's disease (PD) symptoms, due to its convenience and effectiveness. Despite this, its influence on the temporal dynamics of parkinsonism development has yet to be investigated. The present study characterizes behavioral and neurochemical disruptancies underlying the dynamics of parkinsonism development in rats, induced by chronic subcutaneous administration of 2 mg/kg rotenone over the course of 18 days. In this article, the presence of two stages of pathology development in the model in question - the premotor and motor disability stages - are illustrated through a complex assessment of animal behavior, the development of an original neurological symptoms scale, and the establishment of the dynamics of histological and neurochemical changes in the brain. The premotor stage was observed up to 3 days of rotenone administration, and was characterized by a decrease in the motivational component of behavior, shown both in the food-getting task and in the "sucrose preference" test. A 30 % decrease in the number of cells in the substantia nigra pars compacta by the 3rd day of rotenone administration was also shown during the premotor stage. No changes in the metabolism of dopamine and other monoamine mediators were observed at this time. At the same time, acute administration of rotenone caused an increase in the GSH / GSSG ratio by 69 %. The motor stage developed after a decrease in the number of cells in the SNpc by more than 30 %, and was characterized by changes in the dopaminergic system, leading up to a 71 % reduction in dopamine levels in the striatum. It was shown that starting from 4 to 6 days of rotenone injection, experimental group animals begin to develop motor symptoms of Parkinson's disease, including bradykinesia, rigidity and postural instability. The development of motor impairment in all rats of this group was accompanied by significantly reduced activity of the antioxidant system in brain frontal lobe tissue homogenates, as compared to intact rats. Thus, in the used model of rotenone-induced parkinsonism, the dynamics of neuropathology development are described and the premotor stage of the disease is highlighted, which allows future using of this model in developing new approaches for treatment of parkinsonism at an early stage.


Subject(s)
Behavior, Animal/physiology , Corpus Striatum/pathology , Dopaminergic Neurons/pathology , Parkinson Disease, Secondary/pathology , Substantia Nigra/pathology , Animals , Disease Models, Animal , Eating/physiology , Hand Strength/physiology , Male , Parkinson Disease, Secondary/chemically induced , Rats , Rats, Wistar , Rotenone
3.
J Chem Neuroanat ; 110: 101880, 2020 12.
Article in English | MEDLINE | ID: mdl-33160047

ABSTRACT

Exposure of experimental animals to the mitochondrial toxin rotenone is considered to be a model of environmental progression of Parkinson's disease (PD). We investigated the differential vulnerability of various brain regions to generalized inhibition of complex I, induced by subcutaneous rotenone injections for the duration of 1, 3 and 7 days in both rats (2 mg/kg dosage) and mice (4 mg/kg dosage). To examine patterns of metabolic activity changes in the brain, histochemical evaluation of cytochrome C oxidase (COX) activity was performed in post mortem brain sections. Animals displayed a similar time course of neuronal loss in substantia nigra pars compacta (SNpc), reaching 44 % in mice and 42 % in rats by the 7th day. The pattern of COX activity changes, however, was different for the two species. In both experiments, metabolic changes were evident not only in the substantia nigra, but also in non-specific structures (cortex and hippocampus). In mice, a decrease in COX activity was shown mostly for the non-specific areas (V1 cortex and ventral hippocampus) after the single exposure to rotenone. Data from the experiment conducted on rats demonstrated both an acute metabolic decrease in mesencephalic structures (SNpc and nucleus ruber) after a single injection of rotenone and secondary changes in cortical structures (S1 cortex and dorsal hippocampus) after chronic 7 day exposure. These changes reflect the general effect of rotenone on neuronal metabolic rate.


Subject(s)
Brain/drug effects , Electron Transport Complex IV/metabolism , Neurons/drug effects , Parkinson Disease, Secondary/metabolism , Rotenone/pharmacology , Animals , Brain/metabolism , Disease Models, Animal , Dopamine/metabolism , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Neurons/metabolism , Rats
4.
Cells ; 9(2)2020 02 22.
Article in English | MEDLINE | ID: mdl-32098394

ABSTRACT

The main purpose of the review article is to assess the contributions of telomere length and telomerase activity to the cardiac function at different stages of development and clarify their role in cardiac disorders. It has been shown that the telomerase complex and telomeres are of great importance in many periods of ontogenesis due to the regulation of the proliferative capacity of heart cells. The review article also discusses the problems of heart regeneration and the identification of possible causes of dysfunction of telomeres and telomerase.


Subject(s)
Aging/metabolism , Myocytes, Cardiac/metabolism , Organogenesis/physiology , Regeneration/physiology , Telomerase/metabolism , Telomere Homeostasis/physiology , Telomere/metabolism , Adult , Animals , Animals, Newborn , Cell Proliferation/physiology , Humans
5.
Biochim Biophys Acta Mol Cell Res ; 1867(2): 118601, 2020 02.
Article in English | MEDLINE | ID: mdl-31733262

ABSTRACT

The nuclear accumulation of proteins may depend on the presence of short targeting sequences, which are known as nuclear localization signals (NLSs). Here, we found that NLSs are predicted in some cytosolic proteins and examined the hypothesis that these NLSs may be functional under certain conditions. As a model, human cardiac troponin I (hcTnI) was used. After expression in cultured non-muscle or undifferentiated muscle cells, hcTnI accumulated inside nuclei. Several NLSs were predicted and confirmed by site-directed mutagenesis in hcTnI. Nuclear import occurred via the classical karyopherin-α/ß nuclear import pathway. However, hcTnI expressed in cultured myoblasts redistributed from the nucleus to the cytoplasm, where it was integrated into forming myofibrils after the induction of muscle differentiation. It appears that the dynamic retention of proteins inside cytoplasmic structures can lead to switching between nuclear and cytoplasmic localization.


Subject(s)
Cell Nucleus/metabolism , Cytoplasm/metabolism , Troponin I/metabolism , Active Transport, Cell Nucleus , Amino Acid Sequence , Animals , Cell Differentiation , Cell Line, Tumor , Humans , Microscopy, Confocal , Mutagenesis, Site-Directed , Myoblasts/cytology , Myoblasts/metabolism , Nuclear Localization Signals/metabolism , Sequence Alignment , Troponin I/chemistry , Troponin I/genetics , alpha Karyopherins/metabolism , beta Karyopherins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...